It also supports weight loss in people living with obesity or who are overweight
For clinicians, we hope these findings may prompt a more thoughtful, individualized approach when considering these therapies in higher-risk patients who have both obesity and autoimmune disease. I am excited about the combination of medications for these diseases pairing medicines with known benefits to treat the autoimmune disease with a GLP-1RA, said Sheer
Mice were monitored daily for 7 days post-surgery for distress
But not everyones on board
Ipamorelin is a growth hormonereleasing peptide (GHRP) known for its safety profile and targeted action, commonly used for age management, recovery, and metabolic support
Scientists began exploring ways to build on that success, combining GLP-1s with other hormones to make them even more powerful